PARP Inhibitors in Prostate Cancer: A Promise Delivered

Eur Urol Oncol. 2020 Oct;3(5):612-614. doi: 10.1016/j.euo.2020.08.006. Epub 2020 Sep 4.

Authors

Abhishek Tripathi¹, Taylor McFarland², Neeraj Agarwal³

Affiliations

¹ University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA.
² Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
³ Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: neeraj.agarwal@hci.utah.edu.

PMID: 32893185
DOI: 10.1016/j.euo.2020.08.006

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Male
Poly(ADP-ribose) Polymerase Inhibitors* / therapeutic use
Prostatic Neoplasms, Castration-Resistant* / drug therapy

Substances

Poly(ADP-ribose) Polymerase Inhibitors